@misc{indiciae34ea0f1ad9f5,
  title = {Feasibility and Efficacy of Lorlatinib in Japanese Patients With Relapsed/Refractory ALK-Aberrant Neuroblastoma.},
  author = {Takashi Imazu and Hirohito Kubota and Satoshi Saida and Shuro Nishio and Ryunosuke Tojo and Yoshinori Uchihara and Ryo Akazawa and Kagehiro Kouzuki and Yusuke Imanaka and Kimiyoshi Sakaguchi and Masahiro Irie and Itaru Kato and Yoshiyuki Takahashi and Katsutsugu Umeda and Junko Takita},
  year = {2026},
  doi = {10.1002/1545-5017.70511},
  url = {https://pubmed.ncbi.nlm.nih.gov/42499277/},
  note = {Source identifier: 42499277}
}